Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis

Eye

Volumn 25, Issue 7, 2011, Pages 872-880

  Kheirkhah, A ^a   Zavareh, M K ^a   Farzbod, F ^a   Mahbod, M ^b   Behrouz, M J ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NOOR EYE HOSPITAL   (Iran)

Author keywords

allergy; giant papillae; tacrolimus; vernal keratoconjunctivitis

Indexed keywords

EYE DROPS; STEROID; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CONJUNCTIVAL HYPEREMIA; CONTROLLED STUDY; CORNEA EROSION; DRUG EFFICACY; DRUG USE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HYPERTROPHY; INTRAOCULAR FOREIGN BODY; LONG TERM CARE; MALE; OCULAR PRURITUS; PANNUS; PATIENT SAFETY; PHOTOSENSITIVITY; PROSPECTIVE STUDY; TREATMENT OUTCOME; VERNAL CONJUNCTIVITIS;

EID: 79960449557     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2011.75     Document Type: Article

References (29)

1. Bielory L, Frohman LP. Allergic and immunologic disorders of the eye. J Allergy Clin Immunol 1992; 89(1 Part 1): 1-15.
2. Bonini S, Bonini S, Lambiase A, Marchi S, Pasqualetti P, Zuccaro O et al. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term follow-up. Ophthalmology 2000; 107(6): 1157-1163.
3. Tabbara KF. Ocular complications of vernal keratoconjunctivitis. Can J Ophthalmol 1999; 34(2): 88-92.
4. BenEzra D, Peer J, Brodsky M, Cohen E. Cyclosporine eye drops for the treatment of severe vernal keratoconjunctivitis. Am J Ophthalmol 1986; 101(3): 278-282. (Pubitemid 16132651)
5. Secchi AG, Tognon MS, Leonardi A. Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis. Am J Ophthalmol 1990; 110(6): 641-645.
6. Bleik JH, Tabbara KF. Topical cyclosporine in vernal keratoconjunctivitis. Ophthalmology 1991; 98(11): 1679-1684.
7. Sawada S, Suzuki G, Kawase Y, Takaku F. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation. J Immunol 1987; 139(6): 1797-1803. (Pubitemid 17141605)
8. Kobayashi C, Kanai A, Nakajima A, Okumura K. Suppression of corneal graft rejection in rabbits by a new immunosuppressive agent, FK-506. Transplant Proc 1989; 21(1 Part 3): 3156-3158. (Pubitemid 19124697)
9. Nishi M, Herbort CP, Matsubara M, Morishita M, Nishimura M, Nieda M et al. Effects of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat. Invest Ophthalmol Vis Sci 1993; 34(8): 2477-2486. (Pubitemid 23206477)
10. Sloper CM, Powell RJ, Dua HS. Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts. Ophthalmology 2001; 108(10): 1838-1844. (Pubitemid 32905941)
11. Chen J, Zhou Q, Zeng J, Xu JT, Zhao SB,Wang YP. The study of FK506 eye drops preventing and treating immune rejection on limbal allograft transplantation. Zhonghua Yan Ke Za Zhi 2003; 39(9): 550-554 (in Chinese).
12. Yalçindag FN, Incel O, Ozdemir O. Effectiveness of tacrolimus in high-risk limbal allo-graft transplantation. Ann Ophthalmol (Skokie) 2008; 40(3-4): 152-156.
13. Kawashima H, Fujino Y, Mochizuki M. Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats. Invest Ophthalmol Vis Sci 1988; 29(8): 1265-1271.
14. Mochizuki M, Ikeda E, Shirao M, Fujito S, Yoshimura K, Shimada N. Preclinical and clinical study of FK506 in uveitis. Curr Eye Res 1992; 11(Suppl): 87-95.
15. Sloper CM, Powell RJ, Dua HS. Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine. Ophthalmology 1999; 106(4): 723-728. (Pubitemid 30194312)
16. Iwamoto H, Yoshida H, Yoshida O, Fukushima A, Ueno H. Inhibitory effects of FK506 on the development of experimental allergic/immune-mediated blepharoconjunctivitis in Lewis rats by systemic but not by topical administration. Graefes Arch Clin Exp Ophthalmol 1999; 237(5): 407-414. (Pubitemid 29187128)
17. Mayer K, Reinhard T, Reis A, Böhringer D, Sundmacher R. FK 506 ointment 0.1%FA new therapeutic option for atopic blepharitis. Clinical trial with 14 patients. Klin Monbl Augenheilkd 2001; 218(11): 733-736. German. (Pubitemid 33115471)
18. Rikkers SM, Holland GN, Drayton GE, Michel FK, Torres MF, Takahashi S. Topical tacrolimus treatment of atopic eyelid disease. Am J Ophthalmol 2003; 135(3): 297-302. (Pubitemid 36279514)
19. Virtanen HM, Reitamo S, Kari M, Kari O. Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study. Acta Ophthalmol Scand 2006; 84(5): 693-695. (Pubitemid 44317552)
20. Zribi H, Descamps V, Hoang-Xuan T, Crickx B, Doan S. Dramatic improvement of atopic keratoconjunctivitis after topical treatment with tacrolimus ointment restricted to the eyelids. J Eur Acad Dermatol Venereol 2009; 23(4): 489-490.
21. Kymionis GD, Goldman D, Ide T, Yoo SH. Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis. Cornea 2008; 27(2): 228-229. (Pubitemid 351158746)
22. Vichyanond P, Tantimongkolsuk C, Dumrongkigchaiporn P, Jirapongsananuruk O, Visitsunthorn N, Kosrirukvongs P. Vernal keratoconjunctivitis: result of a novel therapy with 0.1% topical ophthalmic FK-506 ointment. J Allergy Clin Immunol 2004; 113(2): 355-358. (Pubitemid 38210564)
23. Miyazaki D, Tominaga T, Kakimaru-Hasegawa A, Nagata Y, Hasegawa J, Inoue Y. Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases. Ophthalmology 2008; 115(6): 988-992.e5.
24. Ohashi Y, Ebihara N, Fujishima H, Fukushima A, Kumagai N, Nakagawa Y et al. A randomized, placebocontrolled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis. J Ocul Pharmacol Ther 2010; 26(2): 165-174.
25. Stumpf T, Luqmani N, Sumich P, Cook S, Tole D. Systemic tacrolimus in the treatment of severe atopic keratoconjunctivitis. Cornea 2006; 25(10): 1147-1149. (Pubitemid 46005849)
26. Anzaar F, Gallagher MJ, Bhat P, Arif M, Farooqui S, Foster CS. Use of systemic T-lymphocyte signal transduction inhibitors in the treatment of atopic keratoconjunctivitis. Cornea 2008; 27(8): 884-888.
27. Nivenius E, van der Ploeg I, Jung K, Chryssanthou E, van Hage M, Montan PG. Tacrolimus ointment vssteroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis. Eye (Lond) 2007; 21(7): 968-975. (Pubitemid 47062083)
28. Sengoku T, Sakuma S, Satoh S, Kishi S, Ogawa T, Ohkubo Y et al. Effects of FK506 eye drops on late and delayed-type responses in ocular allergy models. Clin Exp Allergy 2003; 33(11): 1555-1560. (Pubitemid 37421634)
29. Joseph MA, Kaufman HE, Insler M. Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders. Cornea 2005; 24(4): 417-420. (Pubitemid 40586629)